NasdaqGS - Delayed Quote • USD
OraSure Technologies, Inc. (OSUR)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:03 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 3 | 3 | 2 |
Avg. Estimate | 0.01 | -0.01 | -0.13 | -0.24 |
Low Estimate | -0.05 | -0.03 | -0.21 | -0.27 |
High Estimate | 0.06 | 0.02 | -0.03 | -0.21 |
Year Ago EPS | 0.37 | -0.07 | 0.72 | -0.13 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 5 | 6 | 5 |
Avg. Estimate | 52.1M | 53.73M | 190.8M | 164.77M |
Low Estimate | 51.9M | 49.9M | 180.57M | 150.8M |
High Estimate | 52.56M | 56.77M | 197.06M | 184.51M |
Year Ago Sales | 154.96M | 85.44M | 405.47M | 190.8M |
Sales Growth (year/est) | -66.40% | -37.10% | -52.90% | -13.60% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.14 | -0.08 | 0.04 | 0.08 |
EPS Actual | 0.37 | -0.07 | 0.15 | 0.27 |
Difference | 0.23 | 0.01 | 0.11 | 0.19 |
Surprise % | 164.30% | 12.50% | 275.00% | 237.50% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.01 | -0.01 | -0.13 | -0.24 |
7 Days Ago | 0.01 | -0.01 | -0.13 | -0.24 |
30 Days Ago | -0.01 | -0.01 | -0.13 | -0.24 |
60 Days Ago | 0.02 | -0.03 | -0.24 | -0.28 |
90 Days Ago | 0.02 | -0.03 | -0.24 | -0.28 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | OSUR | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -97.30% | -- | -- | 1.60% |
Next Qtr. | 85.70% | -- | -- | 10.50% |
Current Year | -118.10% | -- | -- | 5.20% |
Next Year | -84.60% | -- | -- | 13.30% |
Next 5 Years (per annum) | 20.00% | -- | -- | 11.22% |
Past 5 Years (per annum) | 23.67% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Evercore ISI Group: In-Line to In-Line | 4/4/2024 |
Maintains | Citigroup: Buy to Buy | 12/11/2023 |
Maintains | JP Morgan: Neutral to Neutral | 11/8/2023 |
Maintains | Stephens & Co.: Equal-Weight to Equal-Weight | 7/17/2023 |
Maintains | Citigroup: Buy | 5/11/2022 |
Maintains | Citigroup: Buy | 2/24/2022 |
Related Tickers
MMSI Merit Medical Systems, Inc.
72.03
+1.46%
ICUI ICU Medical, Inc.
95.77
-1.17%
ANGO AngioDynamics, Inc.
6.26
+2.29%
TFX Teleflex Incorporated
206.56
-0.40%
KRMD KORU Medical Systems, Inc.
2.0800
+0.97%
AKYA Akoya Biosciences, Inc.
3.8000
-1.30%
HBIO Harvard Bioscience, Inc.
3.7000
-6.80%
LMAT LeMaitre Vascular, Inc.
63.26
+1.02%
UTMD Utah Medical Products, Inc.
68.58
+2.01%
AZTA Azenta, Inc.
50.65
+0.32%